Table 3.
Correlation table depicting the extent of similarity or collaboration in research priorities concerning cancer or related healthcare across European countries.
| BE | BG | FR | DE | GR | HU | IT | LU | NL | PT | RO | SK | ES | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BE | 1.00 | ||||||||||||
| BG | 0.58 *,# | 1.00 | |||||||||||
| FR | 0.78 | 0.62 | 1.00 | ||||||||||
| DE | 0.73 | 0.56 | 0.86 | 1.00 | |||||||||
| GR | 0.59 | 0.57 | 0.74 | 0.62 | 1.00 | ||||||||
| HU | 0.67 | 0.72 | 0.66 | 0.69 | 0.73 | 1.00 | |||||||
| IT | 0.84 | 0.67 | 0.79 | 0.73 | 0.79 | 0.80 | 1.00 | ||||||
| LU | 0.75 | 0.48 | 0.85 | 0.77 | 0.62 | 0.50 | 0.77 | 1.00 | |||||
| NL | 0.69 | 0.63 | 0.81 | 0.69 | 0.53 | 0.65 | 0.67 | 0.64 | 1.00 | ||||
| PT | 0.78 | 0.70 | 0.80 | 0.79 | 0.72 | 0.83 | 0.91 | 0.70 | 0.73 | 1.00 | |||
| RO | 0.60 | 0.63 | 0.54 | 0.50 | 0.57 | 0.73 | 0.68 | 0.46 | 0.53 | 0.62 | 1.00 | ||
| SK | 0.80 | 0.55 | 0.82 | 0.81 | 0.67 | 0.62 | 0.79 | 0.79 | 0.69 | 0.71 | 0.64 | 1.00 | |
| ES | 0.79 | 0.47 | 0.75 | 0.75 | 0.66 | 0.75 | 0.88 | 0.75 | 0.65 | 0.85 | 0.68 | 0.76 | 1.00 |
* Belgium—BE, Bulgaria—BG, France—FR, Germany—DE, Greece—GR, Hungary—HU, Italy—IT, Luxembourg—LU, the Netherlands—NL, Portugal—PT, Romania—RO, Slovakia—SK, Spain—ES. 1–0.8 = very high positive correlation, 0.79–0.6 = high positive correlation, 0.59–0.4 = medium positive correlation, 0.39–0.2 = low positive correlation, 0.19–0 = very low positive correlation. # In this table, a high-to-low correlation indicates the extent of similarity in terms of research priorities among countries. Positive or negative correlations signify the direction of the correlation.